EGF and hepatocellular carcinoma: Although we cannot rule out the possibility of Berberine and Costunolide targeting other signaling pathways, we did demonstrate in this study that in certain tumor cells, like PLC/PRF/5, HT29, and HCC-LM3, Berberine and Costunolide inhibit tumor cell proliferation by modulating EGF signaling.